Search Results for 'hcv genotype'

hcv genotype published presentations and documents on DocSlides.

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

by desha

mHCV Genotype II Key to symbols used Global Tra...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

by pasty-toler

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

% of Global HCV Seropositive Cases

% of Global HCV Seropositive Cases

by faith

Global epidemiology of hepatitis C virus infection...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

by pamella-moone

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

by celsa-spraggs

C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

by danika-pritchard

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

Emergence of a HCV genotype genomic variant with

Emergence of a HCV genotype genomic variant with

by kittie-lecroy

Emergence of a HCV genotype genomic variant with e...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Boceprevir with PEG + RBV in Genotype 1

Boceprevir with PEG + RBV in Genotype 1

by caroline

SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...

Ghazala Rubi B.Sc , M.Sc

Ghazala Rubi B.Sc , M.Sc

by badra

,. F.I.B.M.S;. MPhil. (. Mol.Bio. ). PhD (Human G...

This product is intended to be used to guide the selection of treatmen

This product is intended to be used to guide the selection of treatmen

by rosemary

siemens.com/molecular Optimize Treatment Decisions...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

by ellena-manuel

DSV . placebo. Randomisation*. Partial blind. 1...

by karlyn-bohler

BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

by aaron

qd. Non-randomised. Open-label. N =. 21. W12. SV...

by conchita-marotz

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

by ellena-manuel

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

Sofosbuvir-Velpatasvir in Genotype 2

Sofosbuvir-Velpatasvir in Genotype 2

by stefany-barnette

ASTRAL-2*. Phase 3. . Treatment. . Naïve &...

≥ 18 years HCV genotype 1, 2, 4, 5, 6

≥ 18 years HCV genotype 1, 2, 4, 5, 6

by alexa-scheidler

HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...

HIV and viral hepatitis co-infection

HIV and viral hepatitis co-infection

by cheryl-pisano

Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

by luanne-stotts

. HCV Training Workshop. Version 19.0. HCSP/HCV ...

Hepatitis C Overview 1 Updated 9/20/2017

Hepatitis C Overview 1 Updated 9/20/2017

by liane-varnes

2. Introduction . Self-Advocacy through Education...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Telaprevir BID versus q8 in Treatment Naïve GT-1

Telaprevir BID versus q8 in Treatment Naïve GT-1

by volatilenestle

OPTIMIZE (. Study . C211). Phase . 3. Treatment. ...

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

by summer

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand

Internal ControlExpiration DateAmplification Reagent PackCAUTION Hand

by carny

is proportional to the log of the HCV RNA concentr...

CORPORATE HEADQUARTERS

CORPORATE HEADQUARTERS

by yvonne

3043-02 904 Caribbean Drive Sunnyvale, CA 94089 US...

Hepatitis C Dr. Alipour

Hepatitis C Dr. Alipour

by beatrice

Chronic hepatitis C virus (HCV) infection is one o...

Breakout session Ryan White

Breakout session Ryan White

by lydia

Marion Peters. August 2020. ARS Question 1:. Which...

Table 4-1. Interpretation of hepatitis C laboratory results

Table 4-1. Interpretation of hepatitis C laboratory results

by bethany

Test. . Outcome*. Interpretation†. Further. . ...

Hepatitis C Virus HCV Family

Hepatitis C Virus HCV Family

by jacey

. . Flaviviridae. Genera; . Hepacivirus. Enveloped...

Marion G. Peters, MD John V. Carbone, MD, Endowed Chair

Marion G. Peters, MD John V. Carbone, MD, Endowed Chair

by ashley

Professor of Medicine. Chief of Hepatology Researc...

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1

by test

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1 No...

by pasty-toler

OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...

ALLY-3 Design Objective SVR

ALLY-3 Design Objective SVR

by mitsue-stanley

12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...

by giovanna-bartolotta

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

by tawny-fly

Mark Sulkowski, MD. Associate Professor of Medici...